17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Single-cell analyses to tailor treatments

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Single-cell RNA-seq could play a key role in personalized medicine by facilitating characterization of cells, pathways, and genes associated with human diseases such as cancer.

          Related collections

          Most cited references 7

          • Record: found
          • Abstract: found
          • Article: not found

          Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Seq-Well: A Portable, Low-Cost Platform for High-Throughput Single-Cell RNA-Seq of Low-Input Samples

            Single-cell RNA-Seq can precisely resolve cellular states but application to sparse samples is challenging. Here, we present Seq-Well, a portable, low-cost platform for massively-parallel single-cell RNA-Seq. Barcoded mRNA capture beads and single cells are sealed in an array of subnanoliter wells using a semi-permeable membrane, enabling efficient cell lysis and transcript capture. We characterize Seq-Well using species-mixing experiments and PBMCs, and profile thousands of primary human macrophages exposed to tuberculosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Precision oncology for acute myeloid leukemia using a knowledge bank approach

              Peter Campbell, Hartmut Döhner and colleagues present an analysis of genetic mutations and clinical information from 1,540 patients with acute myeloid leukemia, demonstrating the utility of clinical knowledge banks for personalized medicine. They show that use of their approach could reduce the number of hematopoietic cell transplants in patients with AML by up to 25% while maintaining survival rates.
                Bookmark

                Author and article information

                Journal
                Sci Transl Med
                Sci Transl Med
                STM
                Science Translational Medicine
                American Association for the Advancement of Science
                1946-6234
                1946-6242
                20 September 2017
                2017
                : 9
                : 408
                Affiliations
                [1 ]Institute for Medical Engineering & Science (IMES) and Department of Chemistry, Massachusetts Institute of Technology (MIT), Cambridge, MA 02139, USA
                [2 ]Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
                [3 ]Ragon Institute of Massachusetts General Hospital, MIT, and Harvard, Cambridge, MA 02139, USA
                [4 ]The Centre for Personalised Medicine and Division of Pediatrics, Department of Clinical and Experimental Medicine, Linköping University, 58183 Linköping, Sweden
                Author notes
                [* ]Corresponding author. Email: shalek@ 123456mit.edu (A.K.S.); mikael.benson@ 123456liu.se (M.B.)
                Article
                STM-09-eaan4730
                10.1126/scitranslmed.aan4730
                5645080
                28931656
                © 2017 The Authors, some rights reserved

                This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                Categories
                Cancer

                Comments

                Comment on this article